Combined genotypic and phenotypic killer cell Ig-like receptor analyses reveal KIR2DL3 alleles displaying unexpected monoclonal antibody reactivity: identification of the amino acid residues critical for staining.
In humans, recent clinical and experimental data from hematopoietic stem cell transplantation revealed that donor-derived alloreactive NK cells exert a beneficial graft versus leukemia effect. The existence of donor-derived alloreactive NK cells can be predicted on the basis of donor killer cell Ig-like receptor (KIR) gene profile and HLA class I typing of both donor and recipient. Moreover, the size of the alloreactive NK cell population can be directly assessed by the combined use of anti-KIR-specific mAb. In this study, in an attempt to improve the definition of alloreactive NK cell subsets, we assessed the KIR genotype and phenotype in a cohort of 44 donors. This approach allowed the identification of two different KIR2DL3 alleles (KIR2DL3*005 and the novel allele KIR2DL3*015) that did not react with the anti-KIR2DL3-specific ECM41 mAb. In contrast, both alleles were recognized at the cell surface by several mAb reacting with KIR2DL2/L3/S2. Notably, KIR2DL3*005 was also stained by the anti-KIR2DL1/S1-specific EB6B and 11PB6 mAb. Functional analysis revealed that, despite its particular mAb reactivity, the specificity of KIR2DL3*005 for HLA-C molecules did not differ from that of other KIR2DL2/L3 alleles. Finally, site-directed mutagenesis demonstrated that glutamine at position 35 is required for ECM41 staining, whereas glutamic acid 35 and arginine 50 are relevant for staining with EB6B or 11PB6 mAb. Our present data represent a substantial progress in the characterization of the NK cell repertoire and an improved phenotypic/functional definition of given KIR(+) subsets.
Falco
Michela
M
Istituto Giannina Gaslini, Italy.
Romeo
Elisa
E
Marcenaro
Stefania
S
Martini
Stefania
S
Vitale
Massimo
M
Bottino
Cristina
C
Mingari
Maria Cristina
MC
Moretta
Lorenzo
L
Moretta
Alessandro
A
Pende
Daniela
D
D000483:Alleles; D000596:Amino Acids / Q000378:metabolism; D000911:Antibodies, Monoclonal / Q000378:metabolism*; D000937:Antigen-Antibody Reactions / Q000235:genetics; D002460:Cell Line; D002462:Cell Membrane / Q000737:chemistry / Q000235:genetics / Q000276:immunology; D003602:Cytotoxicity, Immunologic / Q000235:genetics; D020869:Gene Expression Profiling / Q000379:methods; D005838:Genotype; D015236:HLA-C Antigens / Q000235:genetics / Q000378:metabolism; D006801:Humans; D016130:Immunophenotyping / Q000379:methods; D007694:Killer Cells, Natural / Q000276:immunology / Q000378:metabolism; D016297:Mutagenesis, Site-Directed; D054344:Receptors, KIR2DL3 / Q000235:genetics* / Q000276:immunology* / Q000378:metabolism; D020539:Sequence Analysis, Protein / Q000379:methods; D013194:Staining and Labeling / Q000379:methods
D000596:Amino Acids; D000911:Antibodies, Monoclonal; D015236:HLA-C Antigens; C038653:HLA-C*03 antigen; C039966:HLA-C*04 antigen; C515078:KIR2DL3 protein, human; D054344:Receptors, KIR2DL3